Organigram enters Germany’s medical cannabis market

The company will be supplying Germany’s Sanity Group with high-grade medical cannabis flower

Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) has added Germany to its list of international markets after securing a new supply agreement with Berlin’s Sanity Group.

The Canadian cannabis company announced the milestone on Tuesday and will be providing high-grade cannabis flower to the German company’s medical division.

The flower being shipped by Organigram was grown at its flagship indoor cultivation facility in Moncton, New Brunswick. Organigram will also be granting Sanity Group strain exclusivity rights on certain genetics it has developed.

“With the German cannabis industry slowly moving toward a recreational adult-use model, we are excited to begin solidifying our relationships with reputable medical cannabis product developers and distributors like Sanity Group,” said Oranigram’s CEO Beena Goldenberg.

“We look forward to bringing Organigram’s high-quality indoor-grown flower to our German medical patients,” said Finn Age Hänsel, Founder and Managing Director of Sanity Group.


Primary Sponsor

Get Connected

Karma Koala Podcast

Top Marijuana Blog